Martin Joseph Joyce

CIK: 0001300858

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALDX

Aldeyra Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
62.7K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.7K shares-
ALDX
Aldeyra Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
7.2K shares-

		Type	Shares	Price		Ownership
Jun 10, 2025	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	62,728	-	-	Direct
Jun 10, 2025	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	1,689	-	-	Direct
Jun 10, 2025	ALDX Aldeyra Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	7,238	-	-	Direct

1-3 of 3 transactions

About JOYCE MARTIN JOSEPH

JOYCE MARTIN JOSEPH (SEC CIK 0001300858) files insider reports with the SEC as Director of Aldeyra Therapeutics, Inc. (ALDX).

Signal8 holds 1 ownership filing by JOYCE MARTIN JOSEPH, a Form 4, filed on Jun 12, 2025. Those filings report 3 transactions, the latest on Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on JOYCE MARTIN JOSEPH's filings is in LEXINGTON, MA.

Recent filings by JOYCE MARTIN JOSEPH

Jun 10, 2025: Grants or awards of ALDX derivative securities (3 lines, Form 4, code A).

Other insiders filing for Aldeyra Therapeutics, Inc. (ALDX)

Miller-Rich Nancy, Director
DOUGLAS RICHARD, Director
Phillips Gary M., Director
Clark William D, Director
Walker Neal, Director
Bronstein Ben, Director

How to read Form 4 transaction codes